Alessandro Armuzzi

Risankizumab Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomized Phase 3 INSPIRE Study

1 University Hospital CHU of Liège, Liège, Belgium, Liège, Belgium; 2 University of Calgary, Calgary, Alberta, Canada; 3 Barts Health NHS Trust, London, United Kingdom; 4 NGERE, Faculty o...

Su Chen ;

W. Rachel Duan ;

Alessandro Armuzzi ;

Luc Biedermann ;

Stefan Schreiber ;

Edouard Louis ;

Remo Panaccione ;

Gareth Parkes ;

Laurent Pevrin-Biroulet ;

Marc Ferrante ;

Britta Siegmund ;

Phillip Levine ;

Gil Y. Melmed , MD;

Jasmina Kalabic ;

Ken Takeuchi , MD, PhD;

Ezequiel Neimark ;

Edward V. Loftus Jr., MD;

Kori Wallace ;

01/11/2024

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Alessandro Armuzzi

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products